Improvement in CD4+ cell counts despite persistently detectable HIV load

New England Journal of Medicine

Volumn 338, Issue 15, 1998, Pages 1074-1075

  Lkvitz, Stuart M ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; FEMALE; HIV PROTEASE INHIBITORS; HUMANS; MALE; REVERSE TRANSCRIPTASE INHIBITORS; VIRAL LOAD;

EID: 0032499143     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/nejm199804093381517     Document Type: Article

References (4)

1. Carpenter CC, Hschl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA ]997;277:1962 9.
2. Saag MS. Use of HIV viral load in clinical practice: hack to the future. Ann Intern Med 1997;126:98,V5.
3. McDonald CK, Kuritzkes DR. Human immunodeficiency virus type 1 protease inhibitors. Arch Intern Med 1997;157:951-9.
4. Autran B, Careelain G, Li TS. et al. Positive effects of combined amirctroviral therapy on CD4+ 1 eell homeostasis and timction in advanced HIV disease. Science 1997;277:112 6.